Free Access
Med Sci (Paris)
Volume 31, Number 6-7, Juin–Juillet 2015
Page(s) 586 - 588
Section Nouvelles
Published online 07 July 2015
  1. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007 ; 448 : 427–434. [CrossRef] [PubMed] [Google Scholar]
  2. Economou M, Filis G, Tsianou Z, et al. Crohn’s disease incidence evolution in North-western Greece is not associated with alteration of NOD2/CARD15 variants. World J Gastroenterol 2007 ; 13 : 5116–5120. [PubMed] [Google Scholar]
  3. Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012 ; 142 : 46–54, e42 ; quiz e30. [CrossRef] [PubMed] [Google Scholar]
  4. Kaur J., A comprehensive review on metabolic syndrome. Cardiol Res Pract 2014 ; 2014 : 943162. [PubMed] [Google Scholar]
  5. Chassaing B, Ley RE, Gewirtz AT. Intestinal epithelial cell toll-like receptor 5 regulates the intestinal microbiota to prevent low-grade inflammation and metabolic syndrome in mice. Gastroenterology 2014 ; 147 : 1363–1377, e17. [CrossRef] [PubMed] [Google Scholar]
  6. Vijay-Kumar M, Aitken JD, Carvalho FA, et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 2010 ; 328 : 228–231. [CrossRef] [PubMed] [Google Scholar]
  7. Carvalho FA, Koren O, Goodrich JK, et al. Transient inability to manage proteobacteria promotes chronic gut inflammation in TLR5-deficient mice. Cell Host Microbe 2012 ; 12 : 139–152. [CrossRef] [PubMed] [Google Scholar]
  8. Caricilli AM, Picardi PK, de Abreu LL, et al. Gut microbiota is a key modulator of insulin resistance in TLR 2 knockout mice. PLoS Biol 2011 ; 9 : e1001212. [CrossRef] [PubMed] [Google Scholar]
  9. Henao-Mejia J, Elinav E, Jin C, et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 2012 ; 482 : 179–185. [PubMed] [Google Scholar]
  10. Elinav E, Strowig T, Kau AL, et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 2011 ; 145 : 745–757. [CrossRef] [PubMed] [Google Scholar]
  11. Chassaing B, Koren O, Goodrich JK, et al. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature 2015 ; 519 : 92–96. [CrossRef] [PubMed] [Google Scholar]
  12. Roberts CL, Keita AV, Duncan SH, et al. Translocation of Crohn’s disease Escherichia coli across M-cells: contrasting effects of soluble plant fibres and emulsifiers. Gut 2010 ; 59 : 1331–1339. [CrossRef] [PubMed] [Google Scholar]
  13. Swidsinski A, Ung V, Sydora BC, et al. Bacterial overgrowth and inflammation of small intestine after carboxymethylcellulose ingestion in genetically susceptible mice. Inflamm Bowel Dis 2009 ; 15 : 359–364. [CrossRef] [PubMed] [Google Scholar]
  14. Johansson ME, Phillipson M, Petersson J, et al. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc Natl Acad Sci USA 2008 ; 105 : 15064–15069. [CrossRef] [Google Scholar]
  15. Chassaing B, Srinivasan G, Delgado MA, et al. Fecal lipocalin 2, a sensitive and broadly dynamic non-invasive biomarker for intestinal inflammation. PLoS One 2012 ; 7 : e44328. [CrossRef] [PubMed] [Google Scholar]
  16. Devkota S, Wang Y, Musch MW, et al. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice. Nature 2012 ; 487 : 104–108. [PubMed] [Google Scholar]
  17. Suez J, Korem T, Zeevi D, et al. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature 2014 ; 514 : 181–186. [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.